Difference between revisions of "Template:Current week ecosystem agenda"
From Bioblast
Tindle Lisa (talk | contribs) |
|||
Line 1: | Line 1: | ||
{{Template:Science for Ukraine}} | {{Template:Science for Ukraine}} | ||
2022 Week | 2022 Week 43 | ||
*'''Oct-24 Mo''' | |||
:::: '''»[[CRUK Beatson Institute Workshop 2022 Glasgow UK]]«''' Oct 24-25 | |||
---- | |||
*'''Oct- | *'''Oct-25 Tu'''- Breast Cancer Awareness Month | ||
:{| | :{| | ||
| width="100" align="center" |[[Image:O2k-Publications.jpg|70px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]] | | width="100" align="center" |[[Image:O2k-Publications.jpg|70px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]] | ||
|''' | |'''"mtSrc-dependent reduction of mtDNA levels lead to OXPHOS deficiency and a more aggressive phenotype [of breast cancer]. Inhibitors specific for mtSrc could therefore restore mitochondrial activity in TNBC cells, and ultimately stop malignancy"''' <br> | ||
* | * Djeungoue-Petga MA, Lurette O, Jean S, Hamel-Côté G, Martín-Jiménez R, Bou M, Cannich A, Roy P, Hebert-Chatelain E (2019) Intramitochondrial Src kinase links mitochondrial dysfunctions and aggressiveness of breast cancer cells. [[Djeungoue-Petga 2019 Cell Death Dis|»Bioblast link«]] | ||
:from the O2k-Network »[[ | :from the O2k-Network »[[CA Moncton Hebert-Chatelain E]]« | ||
|} | |} | ||
---- | ---- | ||
*'''Oct- | *'''Oct-26 We''' | ||
:::: '''»[[13th Targeting Mitochondria Congress 2022 Berlin DE]]«''' Oct 26-28 | |||
---- | ---- | ||
*'''Oct-27 Th''' | |||
---- | ---- | ||
*'''Oct- | *'''Oct-28 Fr''' | ||
Revision as of 08:54, 24 October 2022
- Oroboros declares solidarity against the Russian aggression-war in Ukraine and against all aggression-wars worldwide. - »More details
- -» A future for Ukraine is the future of its science
2022 Week 43
- Oct-24 Mo
- »CRUK Beatson Institute Workshop 2022 Glasgow UK« Oct 24-25
- Oct-25 Tu- Breast Cancer Awareness Month
"mtSrc-dependent reduction of mtDNA levels lead to OXPHOS deficiency and a more aggressive phenotype [of breast cancer]. Inhibitors specific for mtSrc could therefore restore mitochondrial activity in TNBC cells, and ultimately stop malignancy"
- Djeungoue-Petga MA, Lurette O, Jean S, Hamel-Côté G, Martín-Jiménez R, Bou M, Cannich A, Roy P, Hebert-Chatelain E (2019) Intramitochondrial Src kinase links mitochondrial dysfunctions and aggressiveness of breast cancer cells. »Bioblast link«
- from the O2k-Network »CA Moncton Hebert-Chatelain E«
- Oct-26 We
- Oct-27 Th
- Oct-28 Fr